In 2013 was created Venture Founders, which is appeared as VC. The main office of represented VC is situated in the London. The company was established in Europe in United Kingdom.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Venture Founders, startups are often financed by MMC Ventures, Oak Investment Partners, Piton Capital. The meaningful sponsors for the fund in investment in the same round are MMC Ventures, Notion, Piton Capital. In the next rounds fund is usually obtained by Notion, MMC Ventures, SyndicateRoom.
The real fund results show that this VC is 14 percentage points less often commits exit comparing to other companies. The increased amount of exits for fund were in 2019. When the investment is from Venture Founders the average startup value is 1-5 millions dollars. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in 7-12 deals per year. The top activity for fund was in 2017.
Among the most popular portfolio startups of the fund, we may highlight DueDil, Hiring Hub, Hopster TV. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Medical, Data Integration. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The current fund was established by James Codling, Paul Moravek. Besides them, we counted 7 critical employees of this fund in our database.
|3 Wise Ventures||Delaware, United States, Wilmington|
|American General Financial Group||-|
|AXON Connected||Earlysville, United States, Virginia|
|Daytona Ventures GmbH||-|
|Dingxiang Hui Chuangtou||China, Harbin, Heilongjiang|
|Fubo Youxian Gongsi||-|
|GM Capital Partners||Pittsford, United States, Vermont|
|Haufe-Lexware||Baden-Wurttemberg, Freiburg, Germany|
|Jindong Capital Investment||Chengguan District, China, Lhasa|
|K Partners||Australia, Melbourne, Victoria|
|Morgan Stanley Canada Ltd||Canada, Ontario, Toronto|
|PME MTL||Canada, Montréal, Quebec|
|ShengJing360||Beijing, Beijing, China|
|Swastika||China, Hong Kong, Hong Kong Island|
|VMG Partners||California, San Francisco, United States|
|Works Applications||Chiba Prefecture, Japan, Tateyama|
|XP Investimentos||Brazil, Rio de Janeiro, Rio De Janeiro|
|Zhongke Zhanwang||Beijing, Beijing, China|
|$7M||25 Mar 2021||United Kingdom, England, United Kingdom|
|$27M||22 Mar 2021||London, England, United Kingdom|
|$6M||13 Jan 2021||Leicester, England, United Kingdom|
|$27M||08 Jul 2020||London, England, United Kingdom|
|$2M||06 May 2020||London, England, United Kingdom|
|30 Dec 2019||London, England, United Kingdom|
|$1M||13 Jun 2019||London, England, United Kingdom|
|$15M||16 May 2019||London, England, United Kingdom|
|$18M||29 Apr 2019||London, England, United Kingdom|
– Lightpoint Medical announced that it has completed an $8m financing round.
– The funding includes follow-on investment from private investors, Oxford Technology, Venture Founders, Coutts Bank, and new funding from the British Business Bank Future Fund.
– The new capital will be used to finance expanded clinical trials and early commercialization of Lightpoint’s robotic probe, SENSEI®, which has the potential to assist in over 2 million applicable surgical procedures every year in the EU, US, China and Japan.
– SENSEI® received CE Mark approval at the beginning of the year, has been registered successfully with the FDA, and has received approval for sale in Australia.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.